Consolidated Balance Sheets - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 22,849,885	$ 21,606,820
Prepaid expenses and other current assets	726,254	914,275
Total current assets	23,576,139	22,521,095
Property and equipment, net	81,522	88,362
Restricted cash	40,170	40,717
Other noncurrent assets	281,662
Total assets	23,979,493	22,650,174
Current liabilities:
Accounts payable	1,352,240	1,670,369
Accrued expenses	2,008,735	2,186,262
Deferred grant revenue		528,974
Total current liabilities	3,360,975	4,385,605
Commitments and contingencies (Note 9)
Stockholders' equity:
Common stock, $0.001 par value, 400,000,000 shares authorized, 5,481,055 and 3,736,673 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively.	5,481	3,736
Additional paid-in capital	350,971,225	335,644,204
Accumulated other comprehensive loss	(10,627,379)	(10,611,273)
Accumulated deficit	(321,041,872)	(308,083,161)
Total stockholders' equity	19,307,455	16,953,506
Total liabilities and stockholders' equity	23,979,493	22,650,174
Series A Convertible Preferred Stock
Convertible preferred stock:
Series A convertible preferred stock, $0.001 par value, 40,000,000 shares authorized; 56,227 shares issued and outstanding at December 31, 2024 and December 31, 2023.	$ 1,311,063	$ 1,311,063